Both face patent cliffs and regulatory headwinds, but their balance sheets and cash generation tell starkly different stories.
Pfizer Inc. (PFE) News
Latest headlines that mention PFE, newest first · each headline opens the original publisher
- Last price
- $27.82
- Day change
- -0.64%
- Next earnings
- 2026-11-03 BMO
PFE headlines
last 30 daysPfizer is deeply unloved, and for good reason, but don't count this drug maker out just yet.
The company is entering what could be a particularly challenging period.
Many dividend investors may be overlooking Pfizer's stock, and that could be a costly mistake.
Vaxcyte stock catapulted Monday after its experimental pneumococcal vaccine proved it's not inferior to marketed shots from Pfizer and Merck. The post Vaxcyte Catapults After Going Toe-To-Toe With Pfizer, Merck In Vaccine Study appeared first on Investor's Business Daily .
Eli Lilly is dominating the GLP-1 market with nearly 50% revenue growth and a newly approved oral obesity pill. Pfizer is rebuilding its pipeline with obesity drug ambitions and a committed dividend through its transformation.
Novo Nordisk covers its dividend, and Pfizer doesn't, but investors appear increasingly worried about Novo's future.
The crowd is looking at the next couple of years. It should be looking five years into the future.
Novo Nordisk boasts a 33% net margin and fortress balance sheet, while Pfizer trades cheaper but faces major patent cliffs through 2030.
Pfizer has been going through a period of transition.
While Pfizer's dividend looks like a trap, its strong balance sheet and low valuation make it safer.
Pfizer and Bristol Myers Squibb pair big dividends with growing drug pipelines, a rare combination for income-focused pharma investors.
Summit Therapeutics stock jumped Tuesday after AstraZeneca made a $2 billion investment in the smaller biotech. The post AstraZeneca Digs $2 Billion Out Of Its Coffers For Summit Deal, Taking On Bristol, Pfizer, Merck appeared first on Investor's Business Daily .
Also mentioned with PFE
30dHeadlines that tag both tickers
PFE news alerts
Get an alert by email or push when a new headline mentions PFE.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.